Phesgo
Generic name: Hyaluronidase, Pertuzumab, And Trastuzumab
Drug class:
HER2 inhibitors
Usage of Phesgo
Phesgo contains a combination of hyaluronidase, pertuzumab, and trastuzumabis.
Phesgo is a cancer medicine that is used alone or with other medicines to treat early-stage breast cancer.
Phesgo is also used to treat HER2-positive breast cancer that is advanced or has spread to other parts of the body (metastatic).
Phesgo is used for breast cancer only if your tumor tests positive for a protein called human epidermal growth factor receptor 2 (HER2). HER2 protein can speed the growth of cancer cells.
Phesgo side effects
Get emergency medical help if you have signs of an allergic reaction to Phesgo: hives, rash; fever, chills, dizziness; nausea, vomiting, diarrhea; chest pain, difficult breathing; swelling of your face, lips, tongue, or throat.
Phesgo can cause life-threatening heart or lung problems. Call your doctor at once if you have:
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common Phesgo side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Phesgo
You should not be treated with Phesgo if you are allergic to hyaluronidase, pertuzumab, or trastuzumab.
To make sure Phesgo is safe for you, tell your doctor if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
Do not use Phesgo if you are pregnant. It could cause birth defects or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using Phesgo and for at least 7 months after your last dose. Tell your doctor right away if you think you might be pregnant.
If you are pregnant or you become pregnant within 7 months after being treated with this medicine: Your name may be listed on a pregnancy registry to track the effects of hyaluronidase, pertuzumab, and trastuzumab on the baby.
It may not be safe to breastfeed while using Phesgo. Ask your doctor about any risk.
Relate drugs
- Ado-trastuzumab emtansine
- Enhertu
- Fam-trastuzumab deruxtecan
- Fam-trastuzumab deruxtecan-nxki
- Herceptin
- Herceptin Hylecta
- Herzuma
- Herzuma (Trastuzumab Intravenous)
- Herzuma (Trastuzumab-pkrb Intravenous)
- Hyaluronidase and trastuzumab
- Hyaluronidase, pertuzumab, and trastuzumab
- Kadcyla
- Margenza
- Margetuximab
- Margetuximab-cmkb
- Ogivri
- Ogivri (Trastuzumab Intravenous)
- Ogivri (Trastuzumab-dkst Intravenous)
- Ontruzant
- Ontruzant (Trastuzumab Intravenous)
- Ontruzant (Trastuzumab-dttb Intravenous)
- Perjeta
- Pertuzumab
- Pertuzumab, trastuzumab, and hyaluronidase-zzxf
- Phesgo
- Trastuzumab
- Trastuzumab and hyaluronidase-oysk
- Trastuzumab-anns
- Trastuzumab-dkst
- Trastuzumab-dttb
- Trastuzumab-pkrb
- Trazimera
- Tucatinib
- Tukysa
How to use Phesgo
Phesgo is injected under the skin of your thigh. A healthcare provider will give you this injection.
Phesgo is usually given once every 3 weeks for up to 1 year. Your doctor will determine how long to treat you with this medicine.
You will be watched closely for 15 to 30 minutes to make sure you do not have a serious reaction to the injection.
Phesgo can have long lasting effects on your heart. Your heart function may need to be checked every 6 months for at least 2 years after your last dose.
For at least 7 months after your last dose of Phesgo, make sure any doctor treating you with chemotherapy knows that you have received this medicine.
Warnings
Phesgo can cause life-threatening heart or lung problems. Call your doctor at once if you have trouble breathing, swelling or rapid weight gain, fast or pounding heartbeats, or if you feel light-headed.
Do not use if you are pregnant. Use effective birth control during treatment and for at least 7 months after your last dose.
What other drugs will affect Phesgo
Other drugs may affect Phesgo, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions